Pfizer (PFE) Property, Plant & Equipment (Net) (2009 - 2026)

Pfizer (PFE) Property, Plant & Equipment (Net) (2009 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Property, Plant & Equipment (Net) (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn 12.59 Bn
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn 26.54 Bn
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn 23.27 Bn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn 5.69 Bn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn 25.43 Bn
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn 8.22 Bn
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn 5.64 Bn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn 19.40 Bn
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn 7.66 Bn
10 Novartis Ag 109.78 Bn 109.09 Bn - -

Historic Data

Download Data
DateValue
Mar 29, 2026 19.40 Bn
Mar 29, 2026 19.40 Bn
Dec 31, 2025 19.32 Bn
Dec 31, 2025 19.32 Bn
Sep 28, 2025 18.88 Bn
Sep 28, 2025 18.88 Bn
Jun 29, 2025 18.78 Bn
Jun 29, 2025 18.78 Bn
Mar 30, 2025 18.35 Bn
Mar 30, 2025 18.35 Bn
Dec 31, 2024 18.39 Bn
Dec 31, 2024 18.39 Bn
Sep 29, 2024 18.54 Bn
Sep 29, 2024 18.54 Bn
Jun 30, 2024 18.96 Bn
Jun 30, 2024 18.96 Bn
Mar 31, 2024 18.80 Bn
Mar 31, 2024 18.80 Bn
Dec 31, 2023 18.94 Bn
Dec 31, 2023 18.94 Bn